In the original publication [1], an error was identified in Figure 8. Specifically, duplicate images were inadvertently included for the Day 6 gem group and the Day 10 PGPL group. This error occurred during the selection and compilation of images by the authors. The revised, accurate Figure 8 is provided below. The associated text and figure legend remain unchanged. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 8.
Results for cell viability within 3D multicellular pancreatic tumor spheroids of MIAPa-Ca-2. (a) Representative images of spheroids treated with Gem Elaidate, Gem, and PGPLs following 10 days of treatment. (b) Area of spheroids as a function of time with various treatment groups. (n = 3). * p < 0.1; ** p < 0.01; *** p < 0.001.
Reference
- Patel, A.; Saraswat, A.; Patel, H.; Chen, Z.-S.; Patel, K. Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 2023, 15, 182. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).